Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing
Published: 2 October 2024
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Ieva Ruža, Alberto Maria Marra, Ricardo Gómez-Huelgas
